245 related articles for article (PubMed ID: 29684709)
1. The role of natural selection in shaping genetic variation in a promising Chagas disease drug target: Trypanosoma cruzi trans-sialidase.
Gallant JP; Lima-Cordón RA; Justi SA; Monroy MC; Viola T; Stevens L
Infect Genet Evol; 2018 Aug; 62():151-159. PubMed ID: 29684709
[TBL] [Abstract][Full Text] [Related]
2. Recombination-driven generation of the largest pathogen repository of antigen variants in the protozoan Trypanosoma cruzi.
Weatherly DB; Peng D; Tarleton RL
BMC Genomics; 2016 Sep; 17(1):729. PubMed ID: 27619017
[TBL] [Abstract][Full Text] [Related]
3. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
Neres J; Bryce RA; Douglas KT
Drug Discov Today; 2008 Feb; 13(3-4):110-7. PubMed ID: 18275908
[TBL] [Abstract][Full Text] [Related]
4. Design of e-pharmacophore models using compound fragments for the trans-sialidase of Trypanosoma cruzi: screening for novel inhibitor scaffolds.
Miller BR; Roitberg AE
J Mol Graph Model; 2013 Sep; 45():84-97. PubMed ID: 24012872
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, molecular docking and biological evaluation of novel phthaloyl derivatives of 3-amino-3-aryl propionic acids as inhibitors of Trypanosoma cruzi trans-sialidase.
Kashif M; Chacón-Vargas KF; López-Cedillo JC; Nogueda-Torres B; Paz-González AD; Ramírez-Moreno E; Agusti R; Uhrig ML; Reyes-Arellano A; Peralta-Cruz J; Ashfaq M; Rivera G
Eur J Med Chem; 2018 Aug; 156():252-268. PubMed ID: 30006170
[TBL] [Abstract][Full Text] [Related]
6. The Chagas disease domestic transmission cycle in Guatemala: Parasite-vector switches and lack of mitochondrial co-diversification between Triatoma dimidiata and Trypanosoma cruzi subpopulations suggest non-vectorial parasite dispersal across the Motagua valley.
Pennington PM; Messenger LA; Reina J; Juárez JG; Lawrence GG; Dotson EM; Llewellyn MS; Cordón-Rosales C
Acta Trop; 2015 Nov; 151():80-7. PubMed ID: 26215126
[TBL] [Abstract][Full Text] [Related]
7. The diversity of the Chagas parasite, Trypanosoma cruzi, infecting the main Central American vector, Triatoma dimidiata, from Mexico to Colombia.
Dorn PL; McClure AG; Gallaspy MD; Waleckx E; Woods AS; Monroy MC; Stevens L
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005878. PubMed ID: 28957315
[TBL] [Abstract][Full Text] [Related]
8. Trans-sialidase genes expressed in mammalian forms of Trypanosoma cruzi evolved from ancestor genes expressed in insect forms of the parasite.
Briones MR; Egima CM; Eichinger D; Schenkman S
J Mol Evol; 1995 Aug; 41(2):120-31. PubMed ID: 7666441
[TBL] [Abstract][Full Text] [Related]
9. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis).
Miller BR; Roitberg AE
Future Med Chem; 2013 Oct; 5(15):1889-900. PubMed ID: 24144418
[TBL] [Abstract][Full Text] [Related]
11. Effect of primary structure modifications in Trypanosoma cruzi neuraminidase/trans-sialidase activities.
Cremona ML; Pollevick GD; Frasch AC; Campetella O
Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):697-702. PubMed ID: 8832101
[TBL] [Abstract][Full Text] [Related]
12. Trans-sialidase, SAPA amino acid repeats and the relationship between Trypanosoma cruzi and the mammalian host.
Frasch AC
Parasitology; 1994; 108 Suppl():S37-44. PubMed ID: 8084653
[TBL] [Abstract][Full Text] [Related]
13. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite.
Giorgi ME; de Lederkremer RM
Carbohydr Res; 2011 Sep; 346(12):1389-93. PubMed ID: 21645882
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional properties of Trypanosoma trans-sialidase.
Schenkman S; Eichinger D; Pereira ME; Nussenzweig V
Annu Rev Microbiol; 1994; 48():499-523. PubMed ID: 7826016
[TBL] [Abstract][Full Text] [Related]
15. Effect of 4-amino-3-nitrobenzoic acid on the expression level of the trans-sialidase gene in Trypanosoma cruzi epimastigotes.
Vázquez-Jiménez LK; Paz-González AD; Kashif M; Juárez-Rendón KJ; Nogueda-Torres B; Bocanegra-García V; Rivera G
Pak J Pharm Sci; 2019 Mar; 32(2 (Supplementary)):825-829. PubMed ID: 31103978
[TBL] [Abstract][Full Text] [Related]
16. Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi.
Frasch AC
Parasitol Today; 2000 Jul; 16(7):282-6. PubMed ID: 10858646
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the differences of the hydrolytic activity of Trypanosoma cruzi trans-sialidase and Trypanosoma rangeli sialidase: a quantum mechanics-molecular mechanics modeling study.
Bueren-Calabuig JA; Pierdominici-Sottile G; Roitberg AE
J Phys Chem B; 2014 Jun; 118(22):5807-16. PubMed ID: 24814976
[TBL] [Abstract][Full Text] [Related]
18. Genotyping of Trypanosoma cruzi in a hyper-endemic area of Colombia reveals an overlap among domestic and sylvatic cycles of Chagas disease.
Mejía-Jaramillo AM; Agudelo-Uribe LA; Dib JC; Ortiz S; Solari A; Triana-Chávez O
Parasit Vectors; 2014 Mar; 7():108. PubMed ID: 24656115
[TBL] [Abstract][Full Text] [Related]
19. Modulation of catalytic function by differential plasticity of the active site: case study of Trypanosoma cruzi trans-sialidase and Trypanosoma rangeli sialidase.
Demir O; Roitberg AE
Biochemistry; 2009 Apr; 48(15):3398-406. PubMed ID: 19216574
[TBL] [Abstract][Full Text] [Related]
20. trans-sialidase and sialic acid acceptors from insect to mammalian stages of Trypanosoma cruzi.
Briones MR; Egima CM; Acosta A; Schenkman S
Exp Parasitol; 1994 Sep; 79(2):211-4. PubMed ID: 8056084
[No Abstract] [Full Text] [Related]
[Next] [New Search]
